Clinical Trials in Baltimore

Showing 6841-6860 of 17,842 trials

Enhancing Medication-based Analgesia in Humans

NCT02901275

This is a single-group, within-subject, double-blind, double-dummy, placebo and active-controlled study evaluated whether the FDA-approved cannabinoid dronabinol (Marinol) would enhance analgesia, subjective reports, and cognitive performance when compared to the FDA-approved opioid hydromorphone (Dilaudid).

PainCannabisOpioid Use, Unspecified

Johns Hopkins University29 participantsStarted Dec 2016

Baltimore, Maryland, United States

COMPLETEDPhase 4< 1 mile

B/F/TAF Switch Study for HIV-HBV Coinfection

NCT03797014

The primary objective of this study is to evaluate the efficacy and safety of fixed dose combination (FDC) bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults coinfected with both HIV-1 and hepatitis B. As this is a switch study, all eligible subjects enrolled will be switched from their current antiretroviral regimen to B/F/TAF will be followed on treatment for 48 weeks.

HIV-1-infectionHepatitis B

University of Maryland, Baltimore28 participantsStarted Apr 2019

Baltimore, Maryland, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 315 miles

The Lung Screening, Tobacco and Health Project

NCT03200236

The purpose of this study is to compare intensive telephone counseling (ITC) plus the nicotine patch vs. standard telephone counseling plus the nicotine patch (Usual Care; UC) among current smokers undergoing lung cancer screening. Smoking-related outcomes will be examined at three, six and twelve months post-randomization.

Smoking, TobaccoTobacco-Related CarcinomaTobacco Use+1 more

Georgetown University1,114 participantsStarted May 2017

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Moline, Illinois, United States +4 more locations

Enhancing Medication-based Analgesia in Humans

B/F/TAF Switch Study for HIV-HBV Coinfection

The Lung Screening, Tobacco and Health Project

Find Trials by Condition in Baltimore

Efficacy and Safety of Sirolimus in LAM

Vaccine Response With NT-I7

Racial Discrimination, Pain, and the Buffering Influences of Acknowledgment

A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation

Aerosolized Infasurf Treatment Protocol: Aerosolized Infasurf for Spontaneously Breathing Patients With Early RDS (AERO-03)

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Early Signs of Efficacy Study With Riociguat in Adult Homozygous Delta F508 Cystic Fibrosis Patients